Profil Terapi dan Evaluasi Peresepan Pasien Covid-19 Rawat Jalan Di RS Wafa Husada Malang
Therapy Profile and Prescription Evaluation for Covid-19 Out Patients at Wafa Husada Hospital Malang
DOI:
https://doi.org/10.30737/jafi.v6i2.6529Keywords:
Covid 19, evaluasi peresepan, formularium RS, profil pengobatanAbstract
Treatment of COVID-19 patients is differentiated based on the degree of symptoms. The purpose of this study was to determine the therapeutic profile and appropriateness of prescriptions for outpatient COVID-19 at Wava Husada Hospital for the period January–July 202, based on the COVID-19 Management Protocol Book, Edition 2, 2021 and the Hospital Formulary. The research method was a retrospective descriptive observational study with a purposive sampling technique. The research instruments were medical records from SIMRS and patient prescriptions. The results showed that most patients were male (53%), aged 18-44 years (60%). The treatment profile of COVID-19 patients with asymptomatic and mild symptoms, according to therapeutic class, were vitamins (40.3%), cough and cold (12.7%), antipyretic analgesics (9.1%), supplements (8.2%), and macrolide antibiotics (7.6%). The most common types of drugs were vitamin C 500 mg non-acidic (11.8%), vitamin E 400 IU (9.8%) and vitamin D 5000 IU (8.1%). The prescription compliance is 92% of drugs according to the COVID-19 Management Protocol Book Ed. 2 of 2021 and the rationality compliance is 79%. The prescription compliance according to the Hospital Formulary has been fulfilled 100%.
References
[1] E. Burhan, A D.Susanto, S.A. Nasution, E. Ginanjar, C W. Pitoyo, et al., .2022 Protokol Tatalaksana Covid-19. Edisi 4. PDPI, PERKI, PAPDI, PERDATIN, IDAI.
[2] Satgas Covid-19. 2022. Data Sebaran Covid-19. http//: covid 19.go.id. Diakses tanggal 25 September 2022
[3] Badan Pengawas Obat dan Makanan RI. 2020. Informatorium Obat COVID-19 di Indonesia, Cetakan 1. Badan Pengawas Obat dan Makanan Republik Indonesia. Jakarta.
[4] Y. Han and H. Yang, “The transmission and diagnosis of 2019 novel coronavirus infection disease (COVID-19): A Chinese perspective,” J. Med. Virol., vol. 92, no. 6, pp. 639–644, 2020, doi: 10.1002/jmv.25749.
[5] Q. Li et al., “Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia,” N. Engl. J. Med., vol. 382, no. 13, pp. 1199–1207, 2020, doi: 10.1056/nejmoa2001316.
[6] N. F. Shalihah, “Kasus Kematian akibat Covid-19 Indonesia Nomor 7 di Dunia.,” Kompas.com, 2021. https://www.kompas.com/tren/read/2021/10/30/163000265/kasus-kematian- akibat-covid-19-indonesia-nomor-7- di-dunia? page=all [7] Padila, Asuhan Keperawatan Penyakit Dalam. Yogyakarta: Nuha Medika, 2013.
[7] S. M. Ilpaj and Nurwati, “Analisis Pengaruh Tingkat Kematian Akibat Covid-19 Terhadap Kesehatan Mental Masyarakat Di Indonesia.,” Focus J. Pekerj. Sos., vol. 3, p. 1, 2020, doi: https://doi.org/10.24198/focus.v3i1.28123
[8] Kemenkes RI, “Protokol Tata Laksana Covid-19 Buku Saku,” Kementrian Kesehat., p. 105, 2021, [Online]. Available: https://www.papdi.or.id/pdfs/983/Buku Pedoman Tatalaksana COVID-19 5OP Edisi 3 2020.pdf
[9] Kementrian Kesehatan.Republik Indonesia. 2020. Keputusan Menteri Kesehatan Republik Indonesia Nomor HK.01.07/MENKES/200/2020 Tentang Pedoman Penyusunan Formularium Rumah Sakit. Jakarta.
[10] R.M.H Palamba. 2021. Gambaran Terapi Farmakologi Pasien Covid-19 Pada Bulan April-Juni 2020 Di RSUD Kabupaten Mimika. Thesis Tidak Diterbitkan. Jakarta: Fakultas Kedokteran Universitas Kristen Indonesia..
[11] D. Medisa, S. S. Danu dan Rustamaji. 2015. Kesesuaian Resep Dengan Standar Pelayanan Medis dan Formularium Jamkesmas pada Pasien Rawat Jalan Jamkesmas. Jurnal Ilmiah Farmasi Vol. 11 No. 1: 20-28. https://doi.org/10.20885/jif.vol11.iss1.art4
[12] D. Sarvasti. 2020. Pengaruh Gender Dan Manifestasi Kardiovaskular Pada COVID-19. Indonesian Journal of Cardiology. Vol. 41 April – Juni 2020: 128-129
[13] E.Ruhyat. 2021. Perilaku Merokok Di Masa COVID-19. Jurnal Sehat Masada, Vol 15 No 1: 180 – 187
[14] A.Seftiya, K. Kosala. 2021. Epidemiologi Karakteristik Pasien Covid-19 di Kalimantan Utara. Jurnal Sains dan Kesehatan 2021. Vol 3. No 5: 647-648
[15] B.D. Pepitasari, and D.A. Truly 2021. Gambaran Tatalaksana Terapi Pada Pasien COVID-19 Terkonfirmasi di Rumah Sakit X Kota Surakarta Periode Maret – Desember 2020. Indonesian Journal On Medical Science . Vol 8. No 2: 119-125
[16] D.A. Styawan. 2020. Seminar Nasional Official Statistics. Pandemi COVID-19 Dalam Perspektif Demografi. Kebumen: BPS Kabupaten Kebumen.
[17] A.G.Hanggara. 2020. Dinamika Kasus Covid-19 dengan Penambahan Kapasitas Tes PCR. https://corona.jakarta.go.id/id/artikel/dinamika-kasus-covid-19-dengan-penambahan-kapasitas-tes-pcr. Diakses tanggal 20 Maret 2022.
[18] A.Syarif, A., et al. 2016. Farmakologi dan Terapi Edisi 6. Departemen Farmakologi dan Terapeutik Fakultas Kedokteran – Universitas Indonesia. Jakarta.
[19] H. Ariyani, S. Fitriani, and S. Rahma. 2020. “Profil Penggunaan Obat pada Pasien Covid-19 di RSUD Ulin Banjarmasin,” vol.8.no.2.pp.133-148
[20] P.Sestili, and C. Fimognari. 2020. Parasetamol-Induced Glutathione Consumption: Is There a Link With Severe COVID-19 Illness?. Frontiers in Pharmacology;11. doi: 10.3389/fphar.2020.579944.
[21] P.A. Rahmadani, and F.Lestari. 2021. Studi Literatur Beberapa Ekstrak Tanaman yang Memiliki Aktivitas Imunostimulan. Prosiding Farmasi Universitas Islam Bandung. Bandung. Vol 7. No 2: 804-808
[22] R.A. Schwartz. (2020). Azithromycin and COVID-19: Prompt early use at first signs of this infection in adults and children, an approach worthy of consideration. Wiley Dermatologic Therapy;33. https://onlinelibrary.wiley.com/doi/epdf/10.1111/dth.13785. Diakses tanggal 27 Juni 2022
[23] I.Karampela and M. Dalamaga. 2020. Could Respiratory Fluoroquinolones, Levofloxacin and Moxifloxacin, Prove to be Beneficial as an Adjunct Treatment in COVID-19? Arch Med Res. 51(7):741–742. doi: 10.1016/j.arcmed.2020.06.004
[24] Menteri Kesehatan Republik Indonesia. 2008. Keputusan Menteri Kesehatan Republik Indonesia Nomor 129/MENKES/SK/II/2008 Tentang Standar Pelayanan Minimal Rumah sakit
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Tsamrotul Ilmi , Neni Probosiwi , Datin An Nisa Sukmawati, Siti Nurkamah, Sri Lestari, Tantik Tandela
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
- Penulis menyimpan hak cipta dan memberikan jurnal hak penerbitan pertama naskah secara simultan dengan lisensi di bawah Creative Commons Attribution License yang mengizinkan orang lain untuk berbagi pekerjaan dengan sebuah pernyataan kepenulisan pekerjaan dan penerbitan awal di jurnal ini.
- Penulis bisa memasukkan ke dalam penyusunan kontraktual tambahan terpisah untuk distribusi non ekslusif versi kaya terbitan jurnal (contoh: mempostingnya ke repositori institusional atau menerbitkannya dalam sebuah buku), dengan pengakuan penerbitan awalnya di jurnal ini.
- Penulis diizinkan dan didorong untuk mem-posting karya mereka online (contoh: di repositori institusional atau di website mereka) sebelum dan selama proses penyerahan, karena dapat mengarahkan ke pertukaran produktif, seperti halnya sitiran yang lebih awal dan lebih hebat dari karya yang diterbitkan.
Deprecated: json_decode(): Passing null to parameter #1 ($json) of type string is deprecated in /home/ojs.unik-kediri.ac.id/public_html/plugins/generic/citations/CitationsPlugin.php on line 68
